The CenterWatch Monthly Industry Close-Up, September 2017
In 2017, 13% of cancer diagnosed in adults will be rare cancers. Of those, prostate cancer represents 9.6% in the U.S. Prostate cancer is the second most common cancer and the second leading cause of cancer-related death in men in the U.S. According to the National Center for Health Statistics, approximately $11.9 billion is spent each year in the U.S. on prostate cancer treatment.
To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.